Skip to main content
IC
Inhibikase Therapeutics, Inc. (IKT)
NASDAQ: IKT · Real-Time Price · USD
2.190
+0.190 (9.50%)
At close: May 12, 2025, 4:00 PM
2.150
-0.040 (-1.83%)
After-hours: May 12, 2025, 4:28 PM EDT

Revenue by Product

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2017 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2017 - 2018
Protein Kinase Inhibitor Therapeutics
260.50K
Log In
Log In
Log In
Log In
Upgrade
Protein Kinase Inhibitor Therapeutics Growth
111.03%
Log In
Log In
Log In
Log In
Upgrade

Revenue by Geography

Fiscal year is January - December.
Fiscal Year
 FY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2017 - 2018
Period Ending
 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2017 - 2018
United States
260.50K
Log In
Log In
Log In
Log In
Upgrade
United States Growth
111.03%
Log In
Log In
Log In
Log In
Upgrade